If its own site confirms that menu, it will be rated Avoid under our rule, because none of those peptides is on the 503A bulks list or in Category 1 [2].
Our verdict
Not yet ratedWe have not rated this company yet. We could not confirm enough about its prices, FDA record and complaint history to apply our rating rule, so we do not link to it. The facts we could confirm are below.
What we could and could not confirm
Peptide Therapy Rx is listed by the peptide directory MyPeptideMatch as a telehealth service that prescribes compounded medications from 503A and 503B partner pharmacies [1]. We tried to open peptidetherapyrx.com several times on Oct 24, 2026 and could not load any page, so we have not seen its prices, terms, company name or menu first hand. Until we do, we do not rate it and we do not link to it. Our editorial standards explain why a directory is not enough.
The peptides it is listed as selling
The directory lists semaglutide, tirzepatide, NAD+, epithalon, MOTS-c, AOD-9604, thymosin alpha-1, CJC-1295, ipamorelin, BPC-157, KPV, TB-500, GHK-Cu, Semax and Selank [1]. Of those, only NAD+ is in Category 1; GHK-Cu is in Category 1 only in non-injectable forms [2]. The rest are not on the 503A bulks list or in Category 1, so a 503A pharmacy may not compound them [2] [7]. HHS's pending interim peptide policy has not been issued [5] [6].
| Peptide (per directory) | Legal to compound today? | Sources |
|---|---|---|
| BPC-157, TB-500, KPV, MOTS-c, Semax, epithalon | No; favorable but nonbinding 2026 committee votes, no FDA action | [2] [5] |
| CJC-1295, ipamorelin, AOD-9604, thymosin alpha-1 | No; committee voted against in 2024 | [2] |
| Selank | No; listed as nominated but withdrawn | [7] |
| NAD+ | Yes, with a prescription (Category 1) | [2] |
FDA record
We found no FDA warning letter to Peptide Therapy Rx in FDA's warning letter database or in fda.gov search results as of Oct 24, 2026 [3]. FDA's Aug 24, 2026 peptide letters went to research-peptide sellers, not Peptide Therapy Rx [4]. BBB and LegitScript were not checked. See our FDA warning letter tracker.
What to do instead
If you want a peptide that can be prescribed legally, start with our legal peptide price tracker and the NAD+ injection guide. For BPC-157 specifically, see is BPC-157 legal. All rated companies are on our reviews page.
Questions people ask
Is Peptide Therapy Rx legit?
Does Peptide Therapy Rx have an FDA warning letter?
We found none in FDA's warning letter database or fda.gov search results as of Oct 24, 2026 [3].
How much does Peptide Therapy Rx cost?
We could not confirm a price from its own site. A peptide directory lists it as starting at $199 a month, with labs and shipping possibly billed separately [1].
Can Peptide Therapy Rx legally sell BPC-157?
Why is Peptide Therapy Rx not rated?
Because we could not read its own site on Oct 24, 2026 to confirm its prices, menu and terms, and a directory listing is not enough for a rating [1].
Medical review: pending. A licensed clinician has not yet reviewed this page.
Sources
7 cited
- Peptide Therapy Rx vendor listing. MyPeptideMatch, Oct 24, 2026.
- Bulk drug substances nominated for use in compounding under section 503A (categories document). FDA, May 14, 2026.
- Warning letters database. FDA, Oct 24, 2026.
- FDA balances peptide policy with enforcement against unlawful peptide sellers. Sheppard Mullin (FDA Law Update), Sep 18, 2026.
- Peptides at a crossroads: what wellness providers need to know. Holland & Knight, Oct 16, 2026.
- FDA submits interim peptide compounding policy for White House review: what pharmacies should know. Buchanan Ingersoll & Rooney, Oct 16, 2026.
- Certain bulk drug substances for use in compounding that may present significant safety risks. FDA, Apr 22, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.